A flavonoid of cannabis – FBL-03G – has been granted Orphan drug status by the United States Food and Drug Administration. It is anticipated this will now lead to clinical trials with humans for treating pancreatic cancer with cannabis within the next few months. Flavocure, a drug discovery…
Clinical trials anticipated for treating pancreatic cancer with cannabis
